FindMyRecallSubscribe
Class I: serious health riskTerminated

Cubist Pharmaceuticals Cubicin Recall

CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for:…

Cubist Pharmaceuticals, Inc. · Lexington, MA

Risk level
Class I
Reported by FDA
Jun 18, 2014
Recall ID
D-1382-2014
Check your lot numberHow we source this data

Summary

Cubist Pharmaceuticals recalled Cubicin starting Apr 17, 2014. The FDA classified it as Class I (serious health risk) and published enforcement report D-1382-2014 on Jun 18, 2014. Reason: Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.

Product description

CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6.

Lot numbers, UPCs & expiration codes

Lot #: 280453F, Exp 04/16

Where it was sold

Nationwide and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1382-2014
Classification
Class I
Status
Terminated
Recall initiated
Apr 17, 2014
FDA report date
Jun 18, 2014
Quantity
51,500 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Cubist Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1382-2014, exactly as published.

Show all FDA fields
City
Lexington
State
MA
Status
Terminated
Country
United States
Event ID
68025
Address
65 Hayden Ave
Code information
Lot #: 280453F, Exp 04/16
Postal code
02421-7994
Report date
Jun 18, 2014
Product type
Drugs
Recall number
D-1382-2014
Classification
Class I
Recalling firm
Cubist Pharmaceuticals, Inc.
Product quantity
51,500 vials
Termination date
Jul 22, 2016
Reason for recall
Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.
Voluntary / mandated
Voluntary: Firm initiated
Product description
CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6.
Distribution pattern
Nationwide and Puerto Rico.
Recall initiation date
Apr 17, 2014
Initial firm notification
Letter
Center classification date
Jun 12, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1382-2014, published Jun 18, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls